Aβ42의 섬유화 및 독성에 대한 β-Asarone의 저해 효과
Inhibition of Aβ42 Fibrillation and Toxicity with β-Asarone
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Amyloid-β protein (Aβ) is a pathological component of Alzheimer’s disease (AD) by participating in the senile plaque formation in the patient’s brain. Although the exact mechanism of Aβ toxicity is not fully elucidated, it is considered to be closely related to its fibrillation process. For prevention of AD, recent studies have suggested various small molecules which inhibit Aβ fibrillation. In this report, β-asarone found in acorus plant has been investigated as an anti-amyloid molecule. β-Asarone was demonstrated to prevent in vitro fibrillation of Aβ by inducing the oligomer formation that obviously decreased cytotoxicity. Therefore, β-asarone could be suggested as an inhibitory agent of Aβ fibrillation and toxicity, which would help us not only to understand underlying principle of amyloidogenesis mechanism but also to develop a controlling strategy toward AD.
Abstract
Amyloid-β protein (Aβ) is a pathological component of Alzheimer’s disease (AD) by participating in the senile plaque formation in the patient’s brain. Although the exact mechanism of Aβ toxicity is not fully elucidated, it is considered to be closely related to its fibrillation process. For prevention of AD, recent studies have suggested various small molecules which inhibit Aβ fibrillation. In this report, β-asarone found in acorus plant has been investigated as an anti-amyloid molecule. β-Asarone was demonstrated to prevent in vitro fibrillation of Aβ by inducing the oligomer formation that obviously decreased cytotoxicity. Therefore, β-asarone could be suggested as an inhibitory agent of Aβ fibrillation and toxicity, which would help us not only to understand underlying principle of amyloidogenesis mechanism but also to develop a controlling strategy toward AD.
참고문헌 (24)
- Morrison, J. H., "Life and death of neurons in the aging brain", Science, 278, pp.412~419 (1997)
- Fraser, P. E., "Biochemistry of Alzheimer's disease amyloid plaques", Clin. Biochem, 26, pp.339~349 (1993)
- Checler, F., "Processing of the b-amyloid precursor protein and its regulation in Alzheimer's disease", J. Neurochem, 65, pp.1431~1444 (1995)
- Davies, P., "Selective loss of central cholinergic neurons in Alzheimer's disease", Lancet, 308, pp.1403~ (1976)
- Stefani, M., "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution", J. Mol. Med, 81, pp.678~699 (2003)
- Chiti, F., "Protein misfolding, functional amyloid, and human disease", Annu. Rev. Biochem, 75, pp.333~366 (2006)
- Lambert, M. P., "Diffusible, nonfibrillar ligands derived from Ab1-42 are potent contral nervous system neurotoxins", Proc. Natl. Acad. Sci. USA, 95, pp.6448~6453 (1998)
- Klein, W. L., "Targeting small Ab oligomers: the solution to an Alzheimer's disease conundrum?", Trends Neurosci, 24, pp.219~224 (2001)
- Walsh, D. M., "Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long term potentiation in vivo", Nature, 416, pp.535~539 (2002)
- 國家中醫藥管理局, "中華本草(第8卷)", pp.472~478 (1999), 上海 科學技術出版社
- 전국한의과대학 공동교재편찬위원회, "본초학", pp.563~564 (2011), 영림사
- Findeis, M.A., "Approaches to discovery and characterization of inhibitors of amyloid b-peptide polymerization", Biochim. Biophys. Acta, 1502, pp.76~84 (2000)
- Talaga, P., "beta-Amyloid aggregation inhibitors for the treatment of Alzheimer's disease: dream or reality?", Mini Rev. Med. Chem, 1, pp.175~186 (2001)
- Selkoe, D.J., "Alzheimer's disease: mechanistic understanding predicts novel therapies", Ann. Intern. Med, 140, pp.627~638 (2004)
- Tjernberg, L. O., "Arrest of beta-amyloid fibril formation by a pentapeptide ligand", J. Biol. Chem., 271, pp.8545~8548 (1996)
- Permanne, B., "Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?", J. Neural Transm, 62, pp.293~301 (2002)
- Adessi, C., "Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease", J. Biol. Chem, 278, pp.13905~13911 (2003)
- Feng, B. Y., "Small-molecule aggregates inhibit amyloid polymerization", Nat. Chem. Biol, 4, pp.197~199 (2008)
- Necula, M., "Small molecule inhibitors of aggregation indicate that amyloid boligomerization and fibrillization pathways are independent and distinct", J. Biol. Chem, 282, pp.10311~10324 (2007)
- Geng, Y., "Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats", Biological & Pharmaceutical Bulletin, 33, pp.836~843 (2010)
- Matthew, B.i., "Molecular mechanism of Thioflavin-T binding to amyloid fibrils", Biochimica et Biophysica Acta, 1804, pp.1405~1412 (2010)
- Mahiuddin, A., "Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils", Nature Structural. and Molecular bio, 17, pp.561~567 (2010)
- Barrow, C. J., "Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra", J. Mol. Biol, 225, pp.1075~1093 (1992)
- Datki, Z., "Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells", Brain Res Bull, 62, pp.223~229 (2003)